Literature DB >> 7595518

Specific activity of brain palmitoyl-CoA pool provides rates of incorporation of palmitate in brain phospholipids in awake rats.

E Grange1, J Deutsch, Q R Smith, M Chang, S I Rapoport, A D Purdon.   

Abstract

In vivo rates of palmitate incorporation into brain phospholipids were measured in awake rats following programmed intravenous infusion of unesterified [9,10-3H]palmitate to maintain constant plasma specific activity. Animals were killed after 2-10 min of infusion by microwave irradiation and analyzed for tracer distribution in brain phospholipid and phospholipid precursor, i.e., brain unesterified palmitate and palmitoyl-CoA, pools. [9,10-3H]Palmitate incorporation into brain phospholipids was linear with time and rapid, with > 50% of brain tracer in choline-containing glycerophospholipids at 2 min of infusion. However, tracer specific activity in brain phospholipid precursor pools was low and averaged only 1.6-1.8% of plasma unesterified palmitate specific activity. Correction for brain palmitoyl-CoA specific activity increased the calculated rate of palmitate incorporation into brain phospholipids (0.52 nmol/s/g) by approximately 60-fold. The results suggest that palmitate incorporation and turnover in brain phospholipids are far more rapid than generally assumed and that this rapid turnover dilutes tracer specific activity in brain palmitoyl-CoA pool owing to release and recycling of unlabeled fatty acid from phospholipid breakdown.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7595518     DOI: 10.1046/j.1471-4159.1995.65052290.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  23 in total

1.  Fatty acid uptake and incorporation in brain: studies with the perfusion model.

Authors:  Q R Smith; H Nagura
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

2.  Rat brain docosahexaenoic acid metabolism is not altered by a 6-day intracerebral ventricular infusion of bacterial lipopolysaccharide.

Authors:  Thad A Rosenberger; Nelly E Villacreses; Margaret T Weis; Stanley I Rapoport
Journal:  Neurochem Int       Date:  2009-12-22       Impact factor: 3.921

3.  In vivo labeling of brain phospholipids by long-chain fatty acids: relation to turnover and function.

Authors:  S I Rapoport
Journal:  Lipids       Date:  1996-03       Impact factor: 1.880

4.  Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse.

Authors:  C R Jones; T Arai; S I Rapoport
Journal:  Neurochem Res       Date:  1997-06       Impact factor: 3.996

Review 5.  In vivo fatty acid incorporation into brain phosholipids in relation to plasma availability, signal transduction and membrane remodeling.

Authors:  S I Rapoport
Journal:  J Mol Neurosci       Date:  2001 Apr-Jun       Impact factor: 3.444

6.  Evaluation of brain long-chain acylcarnitines during cerebral ischemia.

Authors:  J Deutsch; B Kalderon; A D Purdon; S I Rapoport
Journal:  Lipids       Date:  2000-06       Impact factor: 1.880

7.  Dynamics of docosahexaenoic acid metabolism in the central nervous system: lack of effect of chronic lithium treatment.

Authors:  M C Chang; J M Bell; A D Purdon; E G Chikhale; E Grange
Journal:  Neurochem Res       Date:  1999-03       Impact factor: 3.996

Review 8.  Metabolic heterogeneity and adaptability in brain tumors.

Authors:  Christian E Badr; Daniel J Silver; Florian A Siebzehnrubl; Loic P Deleyrolle
Journal:  Cell Mol Life Sci       Date:  2020-06-06       Impact factor: 9.261

9.  Topiramate does not alter the kinetics of arachidonic or docosahexaenoic acid in brain phospholipids of the unanesthetized rat.

Authors:  Ho-Joo Lee; Sandra Ghelardoni; Lisa Chang; Francesca Bosetti; Stanley I Rapoport; Richard P Bazinet
Journal:  Neurochem Res       Date:  2005-05       Impact factor: 3.996

10.  Chronic imipramine but not bupropion increases arachidonic acid signaling in rat brain: is this related to 'switching' in bipolar disorder?

Authors:  H-J Lee; J S Rao; L Chang; S I Rapoport; H-W Kim
Journal:  Mol Psychiatry       Date:  2008-11-04       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.